BN Business News
Aggiungi la tua azienda →
Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.

Imprese · 09/09/20081 min di lettura

Determination That TEQUIN (Gatifloxacin) Was Withdrawn From Sale for Reasons of Safety or Effectiveness

Traduzione automatica locale · Lingua originale della fonte

Riepilogo

The Food and Drug Administration (FDA) has determined that TEQUIN (gatifloxacin) Tablets, Injection, and Oral Suspension, were withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not accept or approve abbreviated new drug applications (ANDAs) for gatifloxacin oral tablets, injection, or oral suspension that refer to any previously approved dosage forms and strengths of TEQUIN (gatifloxacin).

Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →

Esplora gli approfondimenti

Analisi aziendali →